FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3092352052> ?p ?o ?g. }

• W3092352052 endingPage "2464" @default.
• W3092352052 startingPage "2454" @default.
• W3092352052 abstract "Although new drug discoveries are revolutionizing cancer treatments, repurposing existing drugs would accelerate the timeline and lower the cost for bringing treatments to cancer patients. Our goal was to repurpose CPI211, a potent and selective antagonist of the thromboxane A2-prostanoid receptor (TPr), a G-protein-coupled receptor that regulates coagulation, blood pressure, and cardiovascular homeostasis. To identify potential new clinical indications for CPI211, we performed a phenome-wide association study (PheWAS) of the gene encoding TPr, TBXA2R, using robust deidentified health records and matched genomic data from more than 29,000 patients. Specifically, PheWAS was used to identify clinical manifestations correlating with a TBXA2R single-nucleotide polymorphism (rs200445019), which generates a T399A substitution within TPr that enhances TPr signaling. Previous studies have correlated 200445019 with chronic venous hypertension, which was recapitulated by this PheWAS analysis. Unexpectedly, PheWAS uncovered an rs200445019 correlation with cancer metastasis across several cancer types. When tested in several mouse models of metastasis, TPr inhibition using CPI211 potently blocked spontaneous metastasis from primary tumors, without affecting tumor cell proliferation, motility, or tumor growth. Further, metastasis following intravenous tumor cell delivery was blocked in mice treated with CPI211. Interestingly, TPr signaling in vascular endothelial cells induced VE-cadherin internalization, diminished endothelial barrier function, and enhanced transendothelial migration by tumor cells, phenotypes that were decreased by CPI211. These studies provide evidence that TPr signaling promotes cancer metastasis, supporting the study of TPr inhibitors as antimetastatic agents and highlighting the use of PheWAS as an approach to accelerate drug repurposing." @default.
• W3092352052 created "2020-10-15" @default.
• W3092352052 creator A5004009810 @default.
• W3092352052 creator A5005134586 @default.
• W3092352052 creator A5007479304 @default.
• W3092352052 creator A5023618339 @default.
• W3092352052 creator A5031507912 @default.
• W3092352052 creator A5037945408 @default.
• W3092352052 creator A5041028923 @default.
• W3092352052 creator A5041525182 @default.
• W3092352052 creator A5054762208 @default.
• W3092352052 creator A5068533913 @default.
• W3092352052 creator A5080581533 @default.
• W3092352052 creator A5086600638 @default.
• W3092352052 creator A5086775347 @default.
• W3092352052 date "2020-12-01" @default.
• W3092352052 modified "2023-10-12" @default.
• W3092352052 title "Repurposing of a Thromboxane Receptor Inhibitor Based on a Novel Role in Metastasis Identified by Phenome-Wide Association Study" @default.
• W3092352052 cites W1749356921 @default.
• W3092352052 cites W1963533510 @default.
• W3092352052 cites W1975008160 @default.
• W3092352052 cites W1993389065 @default.
• W3092352052 cites W2005895632 @default.
• W3092352052 cites W2006776184 @default.
• W3092352052 cites W2013808701 @default.
• W3092352052 cites W2026967478 @default.
• W3092352052 cites W2027689184 @default.
• W3092352052 cites W2033278321 @default.
• W3092352052 cites W2034993026 @default.
• W3092352052 cites W2036907940 @default.
• W3092352052 cites W2040593473 @default.
• W3092352052 cites W2067541859 @default.
• W3092352052 cites W2068855429 @default.
• W3092352052 cites W2072213636 @default.
• W3092352052 cites W2073770945 @default.
• W3092352052 cites W2092296830 @default.
• W3092352052 cites W2098600061 @default.
• W3092352052 cites W2102215872 @default.
• W3092352052 cites W2113105800 @default.
• W3092352052 cites W2124894748 @default.
• W3092352052 cites W2125232878 @default.
• W3092352052 cites W2126496132 @default.
• W3092352052 cites W2136023563 @default.
• W3092352052 cites W2144744111 @default.
• W3092352052 cites W2152741971 @default.
• W3092352052 cites W2154084248 @default.
• W3092352052 cites W2314993208 @default.
• W3092352052 cites W2567276480 @default.
• W3092352052 cites W2589610792 @default.
• W3092352052 cites W2595170317 @default.
• W3092352052 cites W2607130335 @default.
• W3092352052 cites W2616849344 @default.
• W3092352052 cites W2769302382 @default.
• W3092352052 cites W2775263281 @default.
• W3092352052 cites W2887379529 @default.
• W3092352052 cites W2891912276 @default.
• W3092352052 cites W2922787085 @default.
• W3092352052 cites W2937447737 @default.
• W3092352052 doi "https://doi.org/10.1158/1535-7163.mct-19-1106" @default.
• W3092352052 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33033174" @default.
• W3092352052 hasPublicationYear "2020" @default.
• W3092352052 type Work @default.
• W3092352052 sameAs 3092352052 @default.
• W3092352052 citedByCount "10" @default.
• W3092352052 countsByYear W30923520522021 @default.
• W3092352052 countsByYear W30923520522022 @default.
• W3092352052 countsByYear W30923520522023 @default.
• W3092352052 crossrefType "journal-article" @default.
• W3092352052 hasAuthorship W3092352052A5004009810 @default.
• W3092352052 hasAuthorship W3092352052A5005134586 @default.
• W3092352052 hasAuthorship W3092352052A5007479304 @default.
• W3092352052 hasAuthorship W3092352052A5023618339 @default.
• W3092352052 hasAuthorship W3092352052A5031507912 @default.
• W3092352052 hasAuthorship W3092352052A5037945408 @default.
• W3092352052 hasAuthorship W3092352052A5041028923 @default.
• W3092352052 hasAuthorship W3092352052A5041525182 @default.
• W3092352052 hasAuthorship W3092352052A5054762208 @default.
• W3092352052 hasAuthorship W3092352052A5068533913 @default.
• W3092352052 hasAuthorship W3092352052A5080581533 @default.
• W3092352052 hasAuthorship W3092352052A5086600638 @default.
• W3092352052 hasAuthorship W3092352052A5086775347 @default.
• W3092352052 hasBestOaLocation W30923520521 @default.
• W3092352052 hasConcept C121608353 @default.
• W3092352052 hasConcept C126322002 @default.
• W3092352052 hasConcept C18903297 @default.
• W3092352052 hasConcept C2779013556 @default.
• W3092352052 hasConcept C502942594 @default.
• W3092352052 hasConcept C519536355 @default.
• W3092352052 hasConcept C60644358 @default.
• W3092352052 hasConcept C71924100 @default.
• W3092352052 hasConcept C86803240 @default.
• W3092352052 hasConcept C96232424 @default.
• W3092352052 hasConcept C98274493 @default.
• W3092352052 hasConceptScore W3092352052C121608353 @default.
• W3092352052 hasConceptScore W3092352052C126322002 @default.
• W3092352052 hasConceptScore W3092352052C18903297 @default.
• W3092352052 hasConceptScore W3092352052C2779013556 @default.
• W3092352052 hasConceptScore W3092352052C502942594 @default.

• next